458
Participants
Start Date
May 31, 2005
Primary Completion Date
May 31, 2007
Study Completion Date
May 31, 2007
Albuferon
Ribavirin
PEG-IFNalfa2a
Royal Prince Alfred Hospital, Camperdown
Concord Repatriation General Hospital, Concord
Westmead Hospital, Westmead
John Hunter Hospital, New Lambton Heights
St. Vincents Hospital, East Melbourne
The Alfred, Melbourne
Western Hospital, Footscray
Royal Melbourne Hospital, Melbourne
Austin Health, Heidelberg
Monash Medical Centre, Clayton
Royal Brisbane Hospital, Herston
Princess Alexandra Hospital, Brisbane
Royal Adelaide Hospital, Adelaide
Royal Perth Hospital, Perth
Sir Charles Gairdner Hospital, Nedlands
Fremantle Hospital, Fremantle
Vseobecna fakultni nemocnice, Prague
University of Marseille, Hopital Saint Joseph, Marseille
University of Berlin, Charite Campus Virchow Klinikum, Berlin
Nuselska poliklinika - Remedis, Prague
Fakultni Thomayerova nemocnice, Prague
Holy Family Hospital, Nazareth
Spitalul Clinic Colentina, Bucharest
University of Hamburg, Hospital Hamburg Eppendorf, Hamburg
Institutul Clinic Fundeni, Bucharest
University of Kiel, Kiel
Nemocnice s poliklinikou Melnik, Mělník
"Spitalul de Boli Infectioase si Tropicale Dr. Victor Babes", Bucharest
University of Hannover, Hanover
B´nai-Zion Medical Center, Haifa
University of Toulouse, Clinique Dieulafoy, Toulouse
Rambam Medical Center, Haifa
Hopital Haut-Leveque, Pessac
University of Grenoble, Hopital Nord, Grenoble
Ambulance pro interni a infekcni nemoci, Ústí nad Labem
University of Duesseldorf, Düsseldorf
University of Bochum, Kliniken Bergmannsheil, Bochum
University of Orleans, Hopital de la Source, Orléans
University of Essen, Essen
University of Angers, CHU Angers, Angers
Rabin Medical Center, Beilinson Campus, Petah Tikva
Klinika infekcnich nemoci, Hradec Králové
Hopital de Brabois, Vandœuvre-lès-Nancy
University of Mainz, Mainz
University of Lille, Hopital Claude Huriez, Lille
University of Frankfurt, Frankfurt
FN Bohunice, Brno
Tel Aviv Sourasky Medical Center, Tel Aviv
University of Saarland, Homburg
University of Heidelberg, Heidelberg
University of Lyon, Hopital de l'Hotel Dieu, Lyon
University of Tuebingen, Tübingen
Slezska nemocnice, Opava
University of Paris, Hopital Saint-Antoine, Paris
University of Paris, Hopital Pitie-Salpetriere, Paris
University of Paris, Hopital Necker, Paris
University of Freiburg, Freiburg im Breisgau
Hadassah Medical Organization, Jerusalem
University of Clichy, Hopital Beaujon, Clichy
University of Creteil, Hopital Henri Mondor, Créteil
Spitalul Clinic de Adulti Cluj-Napoca, Cluj-Napoca
Institutul de Gastroenterologie si Hepatologie, Iași
University of Calgary, Calgary
University of Alberta, Edmonton
University of Alberta- Liver Unit, Edmonton
University of British Columbia, Vancouver
University of Manitoba, Winnipeg
Dalhousie University, Halifax
McMaster Clinic - Hamilton General Hospital, Hamilton
University of Western Ontario, London
Ottawa Civic Hospital, Ottawa
Toronto General Hospital, Toronto
Toronto Western Hospital, Toronto
University of Saskatchewan, Saskatoon
University of Nice, Hopital de l'Archet, Nice
University of Leipzig, Leipzig
Oddzial Chorob Watroby, Bialystok
Katedra i Klinika Chorob Zakaznych i Hepatologii, Bydgoszcz
Katedra i Oddzial Kliniczny Chorob Zakaznych, Chorzów
Wojewodzki Szpital Zespolony, Kielce
Szpital Uniwersytecki w Krakowie, Krakow
Klinika Obserwacyjno Zakazna, Lodz
Oddzial Zakazny, Poznan
Katedra i Klinika Chorob Zakaznych, Szczecin
I Oddzial Dzienny SPZOZ, Warsaw
Klinika Hepatologii i Nabytych Niedoborow Immunologicznych, Warsaw
Katedra i Klinika Chorob Zakaznych, Wroclaw
Lead Sponsor
Human Genome Sciences Inc.
INDUSTRY